FDG PET/MRI to find causes of ongoing hip pain after arthroscopy
Official title: Identifying and Managing Pain Generators in Patients With Persistent Post-hip Arthroscopy Pain Using FDG PET/MRI
Run by University of Wisconsin, Madison · NCT07066709 · Data updated 2026-11-12
This trial will try a single FDG PET/MRI scan to see if it can find inflammation or other problems in adults 18–45 who still have moderate to severe pain at least six months after one hip arthroscopy.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | University of Wisconsin, Madison Academic / other |
| Locations | 1 site (Madison, Wisconsin) |
| Status | Recruiting |
| Started | January 21, 2026 |
| Main results expected | November 2027 |
| Study ends | November 2027 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07066709 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–45 with a single unilateral hip arthroscopy who have persistent hip pain ≥4/10 for at least six months, no evidence of fracture/infection/malignancy, no major pre-existing psychiatric disorder or opioid dependence, not pregnant, and who are candidates for revision surgery or steroid injection.
✕Probably not a fit
Patients with bilateral hip arthroscopy, active fracture, infection or malignancy at six months, major pre-existing mental health conditions or opioid dependence, pregnancy, or those whose hip pain has already resolved are unlikely to benefit from this imaging test.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will recruit adults with a history of unilateral hip arthroscopy and persistent pain to undergo one FDG PET/MRI scan to detect areas of inflammation or hypermetabolic tissue. Participants will include people who go on to revision hip arthroscopy, people whose pain resolved after the first arthroscopy, and people who choose steroid injection for pain management for comparison. The FDG PET/MRI method provides metabolic information beyond conventional MRI and may reveal inflammatory sources not visible on standard imaging. The single-center trial is conducted at the University of Wisconsin–Madison with standard exclusions for fracture, infection, malignancy, major pre-existing psychiatric conditions, opioid dependence, and pregnancy.
Why it matters
Potential benefit: If successful, this imaging approach could help doctors pinpoint sources of post-arthroscopy hip pain to guide whether patients need revision surgery, injections, or other treatments, potentially avoiding unnecessary operations.
How similar studies have gone: FDG PET/MRI has shown sensitivity for detecting focal inflammation and hypermetabolic lesions in other musculoskeletal and inflammatory conditions, but its use specifically to diagnose persistent pain after hip arthroscopy is novel and largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-45 * History of unilateral hip arthroscopy * Does not have evidence of fracture, infection, or malignancy at 6 months post-hip arthroscopy * Does not have evidence of depression or other major mental health conditions before the index hip arthroscopy * Does not have persistent pain that requires opioid use, or does not have a history of opioid abuse * Does not have any comorbidity results in systemic disease limiting function (ASA physical status classification \>3) * Not currently pregnant * Presents with persistent pain (≥4/10 on NRS) for at least 6 months post-hip arthroscopy * Undergo a revision hip arthroscopy with no surgical history on the contralateral limb Exclusion Criteria: * No unilateral hip arthroscopy * Evidence of fracture, infection, or malignancy at 6 months post-hip arthroscopy * Evidence of depression or other major mental health conditions before the index hip arthroscopy * Has persistent pain that requires opioid use, or has a history of opioid abuse * Has any comorbidity results in systemic disease limiting function (ASA physical status classification \<3) * Currently pregnant
Where it's running
-
University of Wisconsin - Madison
Madison, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Andrea Spiker, MD — University of Wisconsin, Madison
- Study coordinator: Amie Armstrong
- Email: armstrong@ortho.wisc.edu
- Phone: 608-262-9790
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ketorolac for pain control after hip arthroscopy
This will test whether ketorolac can control pain and reduce opioid use after hip arthroscopy in adults.
-
Brain-computer visualization training to improve muscle activation after orthopedic surgery
This tests whether adding EEG-based neurofeedback visualization to usual physical therapy helps adults recovering from ACL, hip, or knee surgery activate their muscles better and speed recovery.
-
Biomechanical testing to guide return to sport after hip arthroscopy
This project tries to see if measuring jump, squat, and acceleration movements 3–6 months after hip arthroscopy can predict which athletes can safely return to sport.
-
Comparing absorbable and non-absorbable sutures for hip surgery
This study is testing whether absorbable or non-absorbable stitches work better for people having hip surgery to see which one helps them recover more effectively.
-
Evaluating outcomes of hip preservation surgeries
This study is testing how well hip preservation surgeries, like open and arthroscopic treatments, help people with femoroacetabular impingement feel better after their operation.
-
Comparing AMIC and microfracture for hip cartilage damage
This study is testing whether a new treatment called AMIC works better than microfracture for helping people with hip cartilage damage feel better and improve their quality of life after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.